|
propofol |
9 |
|
analgesia |
6 |
|
chronic pain |
6 |
|
general anesthesia |
6 |
|
postoperative pain |
6 |
|
acute postoperative pain |
5 |
|
general anaesthesia |
5 |
|
neuropathic pain |
5 |
|
pain |
5 |
|
total intravenous anesthesia |
5 |
|
acute |
4 |
|
adult population |
4 |
|
adverse effects |
4 |
|
aging |
4 |
|
brg1 |
4 |
|
colorectal surgery |
4 |
|
diabetes |
4 |
|
distal radial fracture fixation |
4 |
|
endothelin-1 |
4 |
|
inflammatory pain |
4 |
|
infraclavicular nerve block |
4 |
|
ischaemia/reperfusion injury |
4 |
|
isoflurane postconditioning |
4 |
|
myocardial ischemia injury |
4 |
|
nrf2 |
4 |
|
pkc-ε |
4 |
|
postoperative analgesia |
4 |
|
postoperative opioid consumption |
4 |
|
prevalence |
4 |
|
regional anesthesia |
4 |
|
repeated non-invasive limb ischemic preconditioning |
4 |
|
sevoflurane |
4 |
|
stat3 |
4 |
|
acute pain |
3 |
|
anaesthesia |
3 |
|
chronic post-ischaemic pain |
3 |
|
chronic regional pain syndrome |
3 |
|
complications |
3 |
|
endothelin type a receptor |
3 |
|
femoral neck fracture |
3 |
|
fractured hip |
3 |
|
fractured neck of femur |
3 |
|
il-6 |
3 |
|
insomnia |
3 |
|
laparoscopy |
3 |
|
laryngeal mask airway |
3 |
|
mental distress |
3 |
|
meta-analysis |
3 |
|
minimally invasive surgery |
3 |
|
n-methyl-d-aspartate receptors |
3 |
|
neuropathic |
3 |
|
nuclear factor of activated t-cells 5 |
3 |
|
nuclear factor-kappa b |
3 |
|
opioid requirements |
3 |
|
painpaired box gene 2 |
3 |
|
pathophysiological changes |
3 |
|
perceived pain intensity |
3 |
|
perioperative management |
3 |
|
personal wellbeing |
3 |
|
pharmacogenetics |
3 |
|
pi3k |
3 |
|
polymorphisms |
3 |
|
postoperative |
3 |
|
pre-emptive |
3 |
|
preoperative assessment |
3 |
|
psychosocial factors |
3 |
|
pten |
3 |
|
regional |
3 |
|
regional anaesthesia |
3 |
|
risk factor |
3 |
|
supraglottic airway device |
3 |
|
trendelenburg |
3 |
|
analgesic activity |
2 |
|
animal cell |
2 |
|
animal experiment |
2 |
|
animal model |
2 |
|
anti-nociception |
2 |
|
cancer-related pain |
2 |
|
cannabinoids |
2 |
|
caudal epidural |
2 |
|
chronic non-cancer pain |
2 |
|
cohort analysis |
2 |
|
deleted in liver cancer 2 (dlc2) |
2 |
|
depression |
2 |
|
drug mechanism |
2 |
|
fibromyalgia |
2 |
|
gene co-expression |
2 |
|
glutamate acid decarboxylases |
2 |
|
hepatectomy |
2 |
|
histone deacetylase 5 |
2 |
|
il-1β |
2 |
|
labor analgesia |
2 |
|
lumbar epidural |
2 |
|
meperidine |
2 |
|
meta-regression |
2 |
|
microgliap38 |
2 |
|
morphine consumption |
2 |
|
opioid |
2 |
|
opioids |
2 |
|
oral oxycodone |
2 |
|
osteogenesis imperfecta |
2 |
|
osteotomy surgery |
2 |
|
pain management |
2 |
|
pain scores |
2 |
|
patient care management |
2 |
|
patient-centred medical home care |
2 |
|
peripheral neuropathic pain |
2 |
|
pethidine |
2 |
|
pneumoperitoeum |
2 |
|
pneumoperitoneum |
2 |
|
principal component analysis |
2 |
|
propofol tiva |
2 |
|
rhoa rock |
2 |
|
spinal cord stimulation |
2 |
|
support vector machine |
2 |
|
adrenergic agonists - pharmacology |
1 |
|
adrenergic alpha-1 receptor agonists |
1 |
|
adrenergic beta-1 receptor agonists |
1 |
|
adrenergic beta-antagonists - pharmacology |
1 |
|
androgen receptor |
1 |
|
anesthesia, regional |
1 |
|
animals |
1 |
|
brachial plexus |
1 |
|
caffeine - pharmacology |
1 |
|
caffeine-induced intracellular ca2+ concentration transients |
1 |
|
calcium radioisotopes |
1 |
|
calcium signaling - drug effects |
1 |
|
calcium-binding proteins - metabolism |
1 |
|
cells, cultured |
1 |
|
chronic noncancer pain |
1 |
|
early prevention |
1 |
|
electric stimulation |
1 |
|
electrical-induced intracellular ca2+ concentration transients |
1 |
|
gene signature |
1 |
|
isoproterenol - pharmacology |
1 |
|
left ventricular developed pressure |
1 |
|
low back pain |
1 |
|
lumbar prolapsed disc |
1 |
|
machine learning |
1 |
|
male |
1 |
|
myocardial contraction - drug effects |
1 |
|
myocardium - enzymology - metabolism |
1 |
|
na+/ca2+ exchanger |
1 |
|
nerve block |
1 |
|
norepinephrine - pharmacology |
1 |
|
orchiectomy |
1 |
|
peripheral nerves |
1 |
|
phenylephrine - pharmacology |
1 |
|
platelet-rich plasma (prp) |
1 |
|
propanolamines - pharmacology |
1 |
|
randomized controlled trial |
1 |
|
rats |
1 |
|
rats, sprague-dawley |
1 |
|
receptors, adrenergic, alpha-1 - metabolism |
1 |
|
receptors, adrenergic, beta-1 - metabolism |
1 |
|
receptors, androgen - metabolism |
1 |
|
risk prediction |
1 |
|
ryanodine receptor |
1 |
|
ryanodine receptor calcium release channel - metabolism |
1 |
|
sarco(endo)plasmic reticulum ca 2+-atpase |
1 |
|
sarcoplasmic reticulum calcium-transporting atpases - metabolism |
1 |
|
sodium-calcium exchanger - metabolism |
1 |
|
testosterone - administration & dosage - metabolism |
1 |
|
time factors |
1 |
|
transcriptomics |
1 |
|
velocity of contraction and relaxation |
1 |
|
ventricular function, left - drug effects |
1 |
|
ventricular pressure - drug effects |
1 |
